The Free Cannabis pain killers info guide

Pot Pain-Killer Under Consideration for Britons

Mon Feb 18, 9:40 AM ET

LONDON (Reuters) - Britons suffering from multiple sclerosis and other forms of severe pain could legally be prescribed cannabis-based drugs within two years, health chiefs said on Monday.

Sufferers from diseases such as MS, which attacks the central nervous system, have been calling for a pain-relieving cannabis medicine for years and many have broken the law by buying the drug from street dealers.

The government is studying its use as a painkiller, a move likely to reignite debate over relaxing Britain's drug laws.

Canada became the first country to legalize the use of marijuana as a treatment for chronic illnesses last year.

Trials have been set up in Britain to assess the use of cannabis in multiple sclerosis and post-operative pain, Health Minister Lord Hunt said.

Britain's government-funded Medical Research Council is testing cannabis-based tablets on hundreds of MS sufferers.

The results of those tests, expected at the end of 2002, will be forwarded to NICE, Britain's medical watchdog, which will decide whether the cannabis tablets should be offered on prescription through the National Health Service.

"A decision whether one or more of these products will be licensed for official medical use is likely in 2004/5," the Department of Health said in a statement.

Hunt warned against linking the medicinal use of cannabis to its recreational use.

Britain has relaxed its stance on marijuana, saying users caught with small quantities of the drug for personal use will escape with a police caution rather than a fine or jail term.

Cannabis is favored by many MS or cancer sufferers, who say it kills pain and stimulates appetite without the corrosive side effects of many prescription alternatives.

A British company, GW Pharmaceuticals, is developing cannabis-based prescription medicines. It recently said it would expand clinical trials into dealing with cancer pain.

Dr. Geoffrey Guy, executive chairman of GW, said: "This is a positive move by the government."

The Multiple Sclerosis Society, the United Kingdom's largest charity for the 85,000 British people affected by the crippling disorder, said it welcomed any new, safe treatments.

"Anecdotal evidence tells us that existing drugs are not effective in dealing with their symptoms and they do get benefit from using cannabis," said a spokesman for the society.

Cannabis was outlawed in Britain in 1928 and possession and supply remain illegal.

Marijuana seeds, Cannabis seeds, medicine?

Legalised cannabis will be prescribed to people suffering from chronic pain or wasting illnesses under a four-year trial to be run by the NSW Health Department.

How a Premier changed his mind

When the Upper House MP Paul O'Grady rang Premier Bob Carr in January 1995 to tell him he was quitting politics, he also unwittingly set in train the first, tentative steps towards yesterday's major reform.

His immune system depleted by HIV, his weight plummeting to 52 kilograms, Mr O'Grady decided his body couldn't stand the rigours of Parliament any longer. He also explained to the Premier the role cannabis can play for patients living with chronic pain.

How it would work
Only patients registered with the new Office of Medicinal Cannabis would be eligible to take cannabis. The options include:

Allowing them to grow a limited amount of cannabis.

Prescribing cannabis tablets or sprays now being developed, or cannabinoids in capsule form.

Every State on the West Coast(at this time) has medical Marijuana Laws! Get a note from a doctor, stating your condition and that marijuana could be of medical help to you. Your seeds you order through us will be legal and protected under your own laws!(applies to Canada and the United states only) . Just send us a copy in the mail and a brief letter describing the benefits you receive from Marijuana over conventional medicines. Feed the press and help legalize this beneficial compound for all people! Click on the medical cannabis seeds

--------------------------------------------------------------------------------

The State Government aims to introduce draft legislation to govern the trial during the current parliamentary sitting, with the trial to begin next year.

It would include hundreds of people with cancer, HIV, severe or chronic pain, MS-related muscle spasticity, spinal cord injury or nausea caused by chemotherapy.

The Government is yet to outline how the cannabis would be distributed to participants.

Options include allowing them to grow a limited number of marijuana plants, but a spokesman for the Special Minister for State, John Della Bosca, said it was more likely cannabis would be prescribed like other medicines.

Announcing the trial in parliament yesterday, the Premier, Bob Carr, said new cannabis derivatives developed by the British company GW Pharmaceuticals, including an inhaler-type spray and a tablet, would be considered.An Office of Medicinal Cannabis will be set up within the Health Department to run the trial and possibly distribute the drugs.Medicinal users with a medical certificate from a doctor with whom "they had an ongoing and genuine medical relationship" would register with the office annually.People would be ineligible if they had been convicted of a drug offence other than minor personal use, were on parole, or under 18, or pregnant.The Government has been considering the trial since the 2000 Drug Summit, when it set up a working group to study the issue.Mr Della Bosca's spokesman said the draft legislation was complicated, with a series of legal hurdles to be overcome. He said laws must be changed to allow cannabis to be grown or for a drug company to register a cannabis derivative.The Opposition Leader, John Brogden, said he would support the proposal if the cultivation and distribution of cannabis and eligibility criteria for inclusion in the trial were tightly controlled.The Greens MP Lee Rhiannon called for a broader trial open to children dying from degenerative diseases.

Mr Carr emphasised that the Government did not support decriminalisation of cannabis for recreational use.

"The case against the decriminalisation of cannabis is stronger than ever," he said.

He said the working group found that law-abiding people had been forced to turn to the black market to ease their pain.

"No decent government can stand by while fellow Australians suffer like that, while decent, ordinary people feel like criminals for simply medicating themselves."

The president of the NSW branch of the Australian Medical Association, Dr Choong-Siew Yong, said it supported the trial.He said there was strong anecdotal evidence that cannabis eased the symptoms of sufferers of the diseases listed and could be more effective than drugs now available.But he said it was important that "non-traditional" methods of delivery were used.

"You have to be able to properly control the dose," he said.

"Also, smoking cannabis is as harmful or more harmful than smoking tobacco. As a doctor I could not support that."

The spokesman for the National Drug and Alcohol Research Centre, Paul Dillon, said the working group found anecdotal and research evidence supporting the use of cannabis and its derivatives existed, but a greater number of controlled trials were needed.He said clinics in California offered patients cannabis in its natural form, while other United States trials had investigated using so-called canniboids, which contain a synthetic form of the active chemical in cannabis, THC.English trials had already experimented with THC in tablet form, Mr Dillon said.

How the Premier changed his mind

When the Upper House MP Paul O'Grady rang Premier Bob Carr in January 1995 to tell him he was quitting politics, he also unwittingly set in train the first, tentative steps towards yesterday's major reform.His immune system depleted by HIV, his weight plummeting to 52 kilograms, Mr O'Grady decided his body couldn't stand the rigours of Parliament any longer. He also explained to the Premier the role cannabis can play for patients living with chronic pain.